Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Guo (Melbourne, Australia), J. Mann (Melbourne, Australia), N. Smallwood (Melbourne, Australia), N. Goh (Melbourne, Australia). Investigation burden in patients with fibrotic interstitial lung disease in their terminal admission. 4779

Member's Comments

No comment yet.

Related content which might interest you: Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Patients profile and pulmonary rehabilitation in interstitial lung disease Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 Potential causes of acute deterioration in patients with interstitial lung disease Source: Annual Congress 2010 - Different patterns of interstitial lung disease Year: 2010 Palliative and symptomatic care of patients with fibrotic interstitial lung disease Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies Source: International Congress 2016 – Connective tissue disorders Year: 2016 Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 The management of children with interstitial lung disease Source: International Congress 2018 – Difficult paediatric lung disease Year: 2018 A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Pattern and impact of rheumatology referral in patients with ILD and autoimmune features Source: International Congress 2016 – Connective tissue disorders Year: 2016 Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease Source: Eur Respir J 2013; 42: 444-453 Year: 2013 Efficacy of pulmonary rehabilitation in patients with interstitial lung disease Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012 Clinical characteristics of patients with unclassifiable interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 Clubbing in patients with fibrotic interstitial lung diseases Source: International Congress 2017 – ILDs: clinical problems Year: 2017 The clinical value of surgical lung biopsy in 166 patients with suspected interstitial lung disease Source: International Congress 2015 – New insights into IIPs Year: 2015 A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Alveoscopy in diffuse interstitial lung disease Source: Eur Respir J 2007; 30: Suppl. 51, 244s Year: 2007 Effects of pulmonary rehabilitation in patients with interstitial lung disease (ILD) Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009